Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial

Peer Review reports

Original Submission
11 Jul 2023	Submitted	Original manuscript
3 Sep 2023	Reviewed	Reviewer Report - Kirsty Loudon
26 Sep 2023	Author responded	Author comments - Li-Xin Pan
Resubmission - Version 2
26 Sep 2023	Submitted	Manuscript version 2
16 Oct 2023	Author responded	Author comments - Li-Xin Pan
Resubmission - Version 3
16 Oct 2023	Submitted	Manuscript version 3
20 Oct 2023	Author responded	Author comments - Li-Xin Pan
Resubmission - Version 4
20 Oct 2023	Submitted	Manuscript version 4
Publishing
22 Oct 2023	Editorially accepted
5 Jan 2024	Article published	10.1186/s13063-023-07742-x

Back to article page